PPT-Novel Oral Anticoagulants

N OAC Dan Moellentin PharmD BCPS Associate Professor Husson University Strokes in Atrial Fibrillation 15 of strokes are caused by a fib 13 cardiac arrhythmias hospitalizations . Research Advisory Committee. David . Kratville. Senior Environmental Scientist. CDFA – Integrated Pest Control Branch. Vertebrate Pests. Purpose of this training. Overview of rodenticides. History of VPCRAC. Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. Grant M. Greenberg MD, MA, MHSA. Overview. Identify the challenges in diagnosis of Venous Thromboembolic Disease.  . Diagram current protocols/pathways for . evaluation . and treatment of VTE. Review current anticoagulation . Assistant Professor. Department of Internal Medicine – Hospital Medicine Division. Medical Director – UNM Anticoagulation Clinic. Co-Director Antithrombotic Stewardship. Roadmap. Direct oral anticoagulants. Christopher Granger, . MD. Sean Pokorney, MD. . Disclosure (Dr. Granger). Research contracts: AstraZeneca, Daiichi, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, Medtronic Foundation, The Medicines Company, and Boehringer . Dr Than . Kyaw. 27 February 2012. COAGULATION. Complex process of blood clotting. Important part of . hemostasis. Cessation of blood loss from damaged vessel(s). Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis). . This presentation is based on the . December 2013. AHRQ WebM&M Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Margaret . C. Fang. , MD, MPH, University of California, San Francisco. secretory. products into the oral cavity, the salivary glands. In the lab you will also have the opportunity the examine one other specialized epithelial area, the lip. The . oesophagus. is the first part of the alimentary canal. Its . , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. E388 12:E388-90. Dentigerous cyst associated with three teeth Med Oral Patol Oral Cir Bucal 2007; 12:E388-90. Dentigerous cyst associated with Oral osarcoma Med Oral Patol Oral Cir Bucal 2 Oral osarcoma Oral osarcoma Med Oral Patol Oral Cir Bucal 2 Oral osarcoma Primary lei Department of Pediatric Dentistry, University of Texas, Health Science Center, San Antonio.Department of Orofacial Sciences, University of California at San Francisco.Disclosures: FIGURE 1. Squamous Geno J . Merli. , MD, MACP, FSVM, FHM. Professor Medicine & Surgery. Sidney Kimmel Medical College. Thomas Jefferson University Hospitals. Disclosures. Geno J . Merli. , MD. Research Grant BMS-Pfizer: ADIOS study completed 12/2019 Presented ACC Meeting 3/2019.